首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 5期乙型肝炎 => 专家论坛 =>ALT正常的慢性乙型肝炎抗病毒治疗策略
ALT正常的慢性乙型肝炎抗病毒治疗策略
Antiviral therapeutic strategies for chronic hepatitis B patients with a normal alanine aminotransferase level
文章发布日期:2018年04月04日  来源:  作者:丁洋,窦晓光  点击次数:424次  下载次数:75次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:ALT是临床上用于反映肝组织损伤最敏感的生化指标之一。通常认为ALT水平正常的HBV感染者处于免疫耐受状态,肝组织病理无或仅有轻度的炎症,则无需抗病毒治疗。然而ALT水平正常的慢性HBV感染者并非始终处于免疫耐受状态,疾病可隐匿进展为慢性乙型肝炎(CHB),甚至肝硬化、肝细胞癌。因此,ALT水平正常的CHB抗病毒治疗一直是临床研究的热点。主要从ALT与CHB肝组织炎症的关系和ALT水平正常的CHB抗病毒治疗时机等方面进行了阐述。
【Abstract】:Alanine aminotransferase (ALT) is one of the most sensitive biochemical parameters used to reflect the degree of liver injury. It is generally believed that patients with hepatitis B virus (HBV) infection and a normal ALT level are in the immune tolerance state, and no antiviral therapy is required in patients without liver inflammation or those with mild liver inflammation. However, these patients are not always in the immune tolerance state, and the disease can insidiously progress to chronic hepatitis B (CHB), liver cirrhosis, and even hepatocellular carcinoma. Therefore, antiviral therapy for CHB patients with normal ALT has always been a hot topic of clinical research. This article elaborates on the association between ALT and liver inflammation in CHB patients and the timing of antiviral therapy for CHB patients with normal ALT.
【关键字】:肝炎, 乙型, 慢性; 丙氨酸转氨酶; 临床方案
【Key words】:hepatitis B, chronic; alanine transaminase; clinical protocols
【引证本文】:DING Y, DOU XG. Antiviral therapeutic strategies for chronic hepatitis B patients with a normal alanine aminotransferase level[J]. J Clin Hepatol, 2018, 34(5): 926-929. (in Chinese) 丁洋, 窦晓光. ALT正常的慢性乙型肝炎抗病毒治疗策略[J]. 临床肝胆病杂志, 2018, 34(5): 926-929.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号